TSX:NUMI - Post Discussion
Post by
PsilocybinAlpha on Nov 18, 2020 8:26am
Numinus announces trial of psilocybin for substance use
Numinus has announced it will undertake a compassionate access clinical trial of psilocybin-assisted psychotherapy for substance use disorders.
The study will initially involve 30 participants.
Full release here
Be the first to comment on this post